Bio Protocol vs Symbiosis — how do they compare? Bio Protocol trades at Rp514.16 (market cap Rp1,16T, Rp252,63M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Bio Protocol is far larger — about 34037.6× Symbiosis's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 97M / 99,5M SIS (98%) for Symbiosis. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Symbiosis for 12 Days on average.
| BIO | SIS | |
|---|---|---|
Market Cap | Rp1,16T | Rp34,08M |
Volume (24h) | Rp252,63M | Rp2,71M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 97M / 99,5M SIS (98%) |
Typical Hold Time | 16 Days | 12 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →